Table 1.
Reference | Species | Brain Region | Technique | CBVa (ml/100 ml) |
---|---|---|---|---|
(Neil and Ackerman, 1992) | Rat | Whole brain | MRI | 1.00±0.15 |
| ||||
(Duong and Kim, 2000) | Rat | Whole brain | 19F NMR | 0.9±0.2 |
| ||||
(Lee et al., 2001) | Rat | Whole brain | 19F NMR | 0.78 |
| ||||
(Ito et al., 2001) | Human | Cortex | PET | 1.1±0.4 |
| ||||
(Barbier et al., 2001) | Rat | Cortex | MRI | 0.82±0.10 |
| ||||
(An and Lin, 2002b) | Human | Whole brain | MRI | 0.74±0.20 |
| ||||
(Ito et al., 2005) | Human | Cortex | PET | 1.5±0.3 |
| ||||
(Kim and Kim, 2005, 2006) | Rat | Cortex | MRI | 1.1±0.5 |
Caudate, Putamen | 1.3±0.6 | |||
| ||||
(Petersen et al., 2006) | Human | Gray matter | MRI | 0.93±0.0 |
| ||||
(Kim et al., 2007) | Rat | Somatosensory cortex | MRI | 0.83±0.21 |
| ||||
(Brookes et al., 2007) | Human | Gray matter | MRI | 1.7±0.1 |
| ||||
(Hendrikse et al., 2008) | Human | Anterior border zone | MRI | 0.88±0.07 |
Posterior border zone | 1.19±0.11 | |||
Non-border zone GM | 1.64±0.08 | |||
| ||||
(Petersen et al., 2010) | Human | Gray matter | MRI | 0.67±0.16 |
| ||||
(Hua et al., 2011b) | Human | Gray matter | MRI | 0.76±0.17 |
| ||||
(Yan et al., 2012) | Human | Gray matter | MRI | 1.14 – 2.05 |
White matter | 0.46 – 0.55 | |||
| ||||
(Heijtel et al., 2016) | Human | Gray matter | MRI | 0.84±0.35 |
PET | 3.21±0.45 | |||
White matter | MRI | 0.54±0.26 | ||
PET | 1.87±0.31 | |||
Whole brain | MRI | 0.70±0.31 | ||
PET | 2.60±0.38 | |||
| ||||
(Kim et al., 2016) | Human | Gray matter | MRI | 1.4 – 2.3 |
| ||||
(Rane et al., 2016) | Human | Cortex | MRI | 1.58 – 1.89 |
Hippocampus | 2.20 – 2.32 |
The percentage of CBVa/CBVtot depends on the CBVtot value used, which was estimated to be approximately 20–30% in (Piechnik et al., 2008; Sharan et al., 1989; van Zijl et al., 1998).